Schering-Plough results
This article was originally published in The Rose Sheet
Executive Summary
Firm's consumer health-care business in the third quarter advanced 2% to $282 mil., hampered in part by lower sales of sun-care and foot-care products, the company reports Oct. 22. According to the Kenilworth, N.J. firm, sales of sun-care brands, including Bain De Soleil and Coppertone, sank 19% to $17 mil. S-P's net sales in the third quarter declined 2% to $4.5 bil., and net income fell 17% to $477 mil. Separately S-P announces Oct. 23 that the European Commission has approved the company's $41.1 bil. merger with pharma giant Merck, which is slated to close in the fourth quarter (1"The Rose Sheet" March 16, 2009, In Brief)
You may also be interested in...
Coppertone Launching Sun-Protective Hats In Spring; S-P/Merck Are Merged
Schering-Plough/Coppertone plans to roll out a line of sun-protective headwear this spring - including bucket hats, cadet hats, women's and girls' floppies and ball caps, among 23 styles overall - under a partnership with IV Gear, according to a Nov. 2 announcement
Merck acquires Schering-Plough
Pharma company Merck says it plans to keep Schering-Plough's $1.28 bil. consumer health division in its $41.1 bil. acquisition of the firm, announced March 9. Schering-Plough makes and markets sunscreen brands Bain de Soleil and Coppertone within its consumer business. Schering's consumer and animal health businesses could provide a diversified revenue stream and a stable source of cash flow for Merck, which primarily markets drugs. However, Johnson & Johnson has a stake in a partnership with Schering, and may pursue a counter-bid, arbitration, or a deal with Merck (Find more on this topic in 1"The Pink Sheet")
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.